An open-label, dose-escalating, study to evaluate the safety, efficacy and tolerability of oral nadolol for the treatment of adults with mild asthma.
Phase of Trial: Phase I/II
Latest Information Update: 16 May 2016
At a glance
- Drugs Nadolol (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Inverseon
- 05 Feb 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 05 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 May 2008 New trial record.